18 citations
,
August 2015 in “Biochemical and Biophysical Research Communications” This study found that the XEDAR receptor can activate the non-canonical NF-kB pathway involving p100 processing, which is regulated by interactions with TRAF proteins and specific kinases.
June 2026 in “Strathprints: The University of Strathclyde institutional repository (University of Strathclyde)” In this study, researchers found that inhibiting IKKα in patient-derived CCS tumour models reduces tumour viability, supporting the potential for topical IKKα inhibitors as a treatment for CCS.
10 citations
,
October 2019 in “Acta Pharmaceutica” This review discusses the use of herbal medicinal products for treating chronic skin diseases like vitiligo and psoriasis and reports no new clinical results; the authors emphasize the need for standardized extracts and further research.